Dysfunctional T cells due to the abnormal glucose metabolism in patients with primary immune thrombocytopenia
British Journal of Haematology · 2026-01 · 208 (1) · 129-138
DOI: 10.1111/bjh.70229 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, online erschienen am 07.11.2025. Verfasst von Meiwen Tang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Zhongshan Hospital Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Purpura, Thrombocytopenic, Idiopathic, Glucose, T-Lymphocytes, Regulatory. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: Basic and Applied Basic Research Foundation of Guangdong Province.
Abstract (Originalsprache)
To investigate T‐cell glucose metabolism dysfunction in primary immune thrombocytopenia (ITP) and the role of mammalian target of rapamycin complex 1 (mTORC1) in regulatory T‐cell (Treg) suppression function. Gene set enrichment analysis (GSEA) assessed glycolysis and mTORC1 pathways in dysfunctional Tregs from patients with systemic lupus erythematosus (SLE). CD4 + effector T cells (Teffs) were isolated from peripheral blood mononuclear cells (PBMCs) pre‐ and post‐dexamethasone treatment and from healthy controls. The extracellular acidification rate (ECAR) of Tregs and Teffs was measured using the Agilent Seahorse XF96 platform. Flow cytometry evaluated glucose transporter 1 (GLUT1) and phosphorylated S6 (p‐S6) expression. The immune suppression function of Tregs was assessed by mTORC1 inhibiting test. GSEA revealed a possible relation of glycolysis and mTORC1 signalling in dysfunctional Tregs. Both Tregs and Teffs from ITP patients showed elevated ECAR, with Teff ECAR normalizing post‐glucocorticoid treatment. Treg ECAR decreased after treatment, but remained higher than normal level. GLUT1 and p‐S6 expression was significantly higher in ITP Tregs and Teffs, normalizing GLUT1 levels after glucocorticoid therapy. Inhibiting mTORC1 could recover the suppression of ITP Tregs. Dysregulated CD4 + T‐cell glucose metabolism contributes to ITP pathogenesis. Targeting mTORC1 signal may offer a novel therapeutic approach for ITP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Zhongshan Hospital Fudan University, Shanghai, China.
- Department of Hematology, The Fifth Affiliated Hospital, Sun Yat-sen University, Zhuhai, Guangdong, China.
- Department of Hematology, Zhongshan Hospital Qingpu Branch, Fudan University, Shanghai, China.
- Institute of Clinical Science, Zhongshan Hospital Fudan University, Shanghai, China.
- Shanghai Engineering Research Center for Tumor Multitarget Gene Diagnosis, Fudan University, Shanghai, China.
ORCID-Profile: Yunfeng Cheng, Lili Ji
Förderung
- Basic and Applied Basic Research Foundation of Guangdong Province
Zitieren
APA
Tang, M., Li, B., Zhuang, J., Zhan, Y., Xie, F., Ye, H., Li, Z., Pang, W., Cheng, Y., & Ji, L. (2026). Dysfunctional T cells due to the abnormal glucose metabolism in patients with primary immune thrombocytopenia. British Journal of Haematology, 208(1), 129-138. https://doi.org/10.1111/bjh.70229
Vancouver
Tang M, Li B, Zhuang J, Zhan Y, Xie F, Ye H, et al. Dysfunctional T cells due to the abnormal glucose metabolism in patients with primary immune thrombocytopenia. British Journal of Haematology. 2026;208(1):129-138. doi:10.1111/bjh.70229
BibTeX
@article{Tang2026,
author = {Tang, Meiwen and Li, Bixiang and Zhuang, Juan and Zhan, Yanxia and Xie, Feng and Ye, Honghui and Li, Zhitao and Pang, Wenzheng and Cheng, Yunfeng and Ji, Lili},
title = {Dysfunctional T cells due to the abnormal glucose metabolism in patients with primary immune thrombocytopenia},
journal = {British Journal of Haematology},
year = {2026},
volume = {208},
number = {1},
pages = {129--138},
doi = {10.1111/bjh.70229}
}
EUVIMED